FibroScan overestimated advanced fibrosis and cirrhosis in patients with class 3 obesity and metabolic dysfunction-associated steatotic liver disease.

Liver fibrosis is a major global health concern, developing as a result of chronic liver diseases (CLDs) such as viral ...

Maternal diet, excess bile acid and liver disease - Moms who eat a high-fat, high-sugar diet during pregnancy can increase ...

Ready to save your liver? Transcription factors are paving the way for metabolic dysfunction-associated fatty liver disease ...

Researchers from Columbia University and the German Cancer Center have found that stellate cells—star-shaped liver cells long ...

Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...

Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...

The number one unmet need is that we don't have a good handle on who's at risk, because patients generally don't have too ...

Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...

THR-beta agonists are the only medication approved to treat metabolic dysfunction–associated steatohepatitis (MASH), a severe ...

Alcohol doesn’t just impact the liver, it wreaks havoc on the entire digestive system. From inflamed gums and acid reflux to ...

Medically reviewed by Jay N. Yepuri, MD FibroScan is the brand name for transient elastography, an abdominal ultrasound that ...